Regulations and Compliance

  1. Inside The Phased, Risk-Based Approach For CGT Materials 4/1/2026

    In this segment of Cell & Gene Live, Anthony Blaszczyk, Ph.D., Senior Scientist at the U.S. Pharmacopeia, and Basak Clements, Ph.D., Founder and Senior Advisor at biomatria, were joined by Cell & Gene Chief Editor Erin Harris to discuss the efforts that are underway to close the gap in particulate guidance for cell and gene therapy by developing new best practices and fostering cross-industry collaboration, recognizing that particulates remain a complex, unsolved challenge.